NCT06640842Completed
Brain Health in Midlife
Brain Health in Midlife (ADORE BRAIN)
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to learn if hypertensive disorders during pregnancy affects brain health in midlife.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 24 (actual)
- First submitted
- 29 Aug 2024
- Start date
- 23 Sept 2024
- Primary completion date
- 13 Jun 2025
- Lead sponsor
- University of Kansas Medical Center
- Diseases
- High blood pressure, Alzheimer disease
- NCT number
- NCT06640842
What you commit to
- Study type: Observational
- Participants enrolled: 24
- From 23 Sept 2024 to the primary completion date, 13 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of seizures or Epilepsy
Other
- Pregnant at screening
- Ineligible to complete MRI due to metal in the body
Who the study is looking for
- Participated in the ADORE trial ( R01 HD083292)
Age in the registry: 18 years to 54 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Kansas Medical Center Coordinator of this site? Confirm its status | Kansas City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.